Navco Pharmaceuticals Inc.
NAV.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -98.34% | -96.89% | -98.50% | -- | 5,381.82% |
| Total Receivables | -11.92% | 43.86% | 153.85% | -- | -- |
| Inventory | -- | -- | -46.15% | -- | -- |
| Prepaid Expenses | -- | -- | -85.13% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -87.17% | -89.62% | -87.87% | -- | -- |
|
|
|||||
| Total Current Assets | -87.17% | -89.62% | -87.87% | -- | -- |
| Net Property, Plant & Equipment | -99.62% | -99.26% | -21.03% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 1,538.44% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -91.49% | -91.91% | -29.57% | -- | -- |
|
|
|||||
| Total Accounts Payable | 47.12% | 58.75% | 8.03% | -- | -- |
| Total Accrued Expenses | -22.15% | -75.44% | -9.40% | -- | -- |
| Short-term Debt | -85.46% | 520.00% | 49.94% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -66.00% | -24.21% | 6.32% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 35.15% | -- | -- | -- |
| Total Other Current Liabilities | -- | 35.15% | -- | -- | -- |
| Total Current Liabilities | 20.44% | 23.84% | 39.30% | -- | -- |
|
|
|||||
| Total Current Liabilities | 20.44% | 23.84% | 39.30% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -85.46% | 520.00% | 49.94% | -- | -- |
| Capital Leases | -- | -- | -17.42% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.11% | 10.51% | 31.49% | -- | -- |
|
|
|||||
| Common Stock & APIC | 10.12% | 20.14% | -31.56% | -- | -- |
| Retained Earnings | -24.63% | -45.39% | 12.45% | -- | -- |
| Treasury Stock & Other | 10.05% | 20.04% | 611.65% | -- | -- |
| Total Common Equity | -331.42% | -1,081.73% | -96.91% | -- | 76.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -331.42% | -1,081.73% | -96.91% | -- | 76.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -331.42% | -1,081.73% | -96.91% | -- | 76.01% |
|
|
|||||